Fampridine
Title: Fampridine
CAS Registry Number: 504-24-5
CAS Name: 4-Pyridinamine
Additional Names: 4-aminopyridine; g-aminopyridine; 4-pyridylamine; 4-AP
Manufacturers' Codes: EL-970
Molecular Formula: C5H6N2
Molecular Weight: 94.11
Percent Composition: C 63.81%, H 6.43%, N 29.77%
Literature References: Potassium channel blocker. Prepn: A. Kirpal, Monatsh. Chem. 23, 244 (1902); R. Camps, Arch. Pharm. 240, 345 (1902); C. R. Hauser, G. A. Reynolds, J. Org. Chem. 15, 1224 (1950). Prolongs action potential in demyelinated nerve fibers: R. M. Sherratt et al., Nature 283, 570 (1980). HPLC determn in serum: A. van der Horst et al., J. Chromatogr. 574, 166 (1992). Neurophysiology and clinical efficacy in multiple sclerosis: H. A. M. van Diemen et al., J. Neurol. Sci. 116, 220 (1993). Clinical evaluation: C. H. Polman et al., Arch. Neurol. 51, 1136 (1994). Review of pharmacology and efficacy of aminopyridines in MS: C. T. Bever, Jr., Ann. Neurol. 36, S118-S121 (1994).
Properties: Crystals from CHCl3, mp 158-159°. Sol in water, alcohol; slightly sol in benzene, ether; very slightly sol in ligroin.
Melting point: mp 158-159°
Therap-Cat: In treatment of multiple sclerosis.
Keywords: Potassium Channel Blocker.

Others monographs:
DiethylzincBenzoguanamineLunacrineNitrohydrochloric Acid
NifurtimoxDocarpamineAcetyl IodideFlupyrsulfuron-methyl
TofisopamMenthyl ValerateBaptigeninEseridine
1,2-DimethylhydrazineTriphenylmethane2,4'-BiphenyldiamineIsobutyl p-Aminobenzoate
©2016 DrugLead US FDA&EMEA